Concepedia

Treatment with rituximab affects both the cellular and the humoral arm of the immune system in patients with SLE

Therese Vallerskog, Iva Gunnarsson, Mona Widhe, Anke P. Risselada, Lars Klareskog, Ronald van Vollenhoven, Vivianne Malmström, Christina Trollmo

Clinical Immunology · 2006 · 239 citations · 46 references

DOI

Concepts

References

46

The 1982 revised criteria for the classification of systemic lupus erythematosus

Eng M. Tan, Alan S. Cohen, James F. Fries et al. · Arthritis & Rheumatism · 1982 · 14.6K citations

, , +14

Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.

Peter McLaughlin, A.J. Grillo-López, Brian K. Link et al. · Journal of Clinical Oncology · 1998 · 2.8K citations

, , +17

Efficacy of B-Cell–Targeted Therapy with Rituximab in Patients with Rheumatoid Arthritis

Jonathan Edwards, L Szczepański, Jacek Szechiński et al. · New England Journal of Medicine · 2004 · 2.6K citations · Full text

, , +17

Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20

ME Reff, K Carner, KS Chambers et al. · Blood · 1994 · 1.9K citations · Full text

, , +14

Maintenance of Serological Memory by Polyclonal Activation of Human Memory B Cells

Nadia L. Bernasconi, Elisabetta Traggiai, Antonio Lanzavecchia · Science · 2002 · 1.3K citations

, , +17